PPP1R1B and schizophrenia: DARPP-32 has been proposed to act as an integrator of dopaminergic and glutamatergic signaling [67] and elevated levels of its truncated isoform were reported in schizophrenia, bipolar disorders and major depression as well as poor cognitive functioning [40].